Home > Insider Trading > Filing (0001225208-20-013619)

Filing Details

Accession Number:: 0001225208-20-013619
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-17 21:57:58
Reporting Period:: 2020-11-17

Accepted Time:: 2020-11-17 21:57:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1099800	Edwards Lifesciences Corp	EW	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	364316614

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1204551	A Michael Mussallem	One Edwards Way Irvine CA 92614	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-17	98,550	$13.98	309,770	No	4	M	Direct
Common Stock	Disposition	2020-11-17	600	$87.37	309,170	No	4	S	Direct
Common Stock	Disposition	2020-11-17	2,400	$86.51	306,770	No	4	S	Direct
Common Stock	Disposition	2020-11-17	30,000	$0.00	276,770	No	4	G	Direct
Common Stock	Disposition	2020-11-17	30,345	$84.82	246,425	No	4	S	Direct
Common Stock	Disposition	2020-11-17	35,205	$85.19	211,220	No	4	S	Direct
Common Stock	Acquisiton	2020-11-17	30,000	$0.00	2,853,582	No	4	G	Indirect	By Living Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	G	Direct
No	4	S	Direct
No	4	S	Direct
No	4	G	Indirect	By Living Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Acquire)	Disposition	2020-11-17	98,550	$0.00	98,550	$13.98

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
558,300	2014-06-08	2021-05-07	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	371,741	Indirect	401(k)

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 3, 2020.
This transaction was executed in multiple trades at prices ranging from $87.0800 to $87.7900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $86.0200 to $87.0100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $84.0950 to $85.0050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $85.0100 to $85.9500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.